A randomized trial showed no benefit from adding a daily fish oil supplement versus placebo to psychotherapy for youth with depression. The trial evaluated children and adolescents with ...
The novel serotonin norepinephrine reuptake inhibitor (SNRI) ammoxetine may effectively treat major depressive disorder (MDD) while avoiding some side effects common to other antidepressants, new ...
The UK Medical and Healthcare products Regulatory Agency (MHRA) has granted approval for Cybin to initiate the randomised EMBRACE study to assess CYB003 for the adjunctive treatment of major ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results